JPRN-UMIN000052475已完成Unknown
Survey on Minimal Residual Disease (MRD) Measurement in Multiple Myeloma - Survey on Minimal Residual Disease (MRD) Measurement in Multiple Myeloma
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- Sanofi K.K.
- 入组人数
- 158
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Not applicable
研究者
相似试验
已完成
不适用
Minimal residual disease (MRD) monitoring in neuroblastoma to improve MRD based risk stratificatiosmall round blue cell tumor10029211neuroblastomaNL-OMON30826Academisch Medisch Centrum60
已完成
不适用
Non-invasive MRD Assessment in Multiple MyelomaMyelomaNCT05625971Rajshekhar Chakraborty, MD36
已完成
不适用
Prospective evaluation of minimal residual disease in acute myeloid leukemia using TIM-3 as a leukemia markeracute myeloid leukemiaJPRN-UMIN000030977Department of Medicine and Biosystemic Sciences, Kyushu University Graduate School of Medicine50
进行中（未招募）
不适用
Eradication of Minimal Residual Disease (MRD) in patients with Chronic Lymphocytic Leukaemia (CLL) with Alemtuzumab: A Phase II Study - UKCLL07Chronica Lymphocytic Leukaemia (CLL)EUCTR2006-000053-22-GBeeds Teaching Hospitals NHS Trust54
招募中
不适用
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLCNon-small Cell Lung CancerNCT06198868Jiangsu Cancer Institute & Hospital60